首页> 外文期刊>The Lancet Public Health >The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study
【24h】

The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study

机译:贲门和非贲门胃癌的相对和可归因于与幽门螺杆菌(幽门螺杆菌)(斜斜肌:斜体>感染):一个案例 - 队列研究

获取原文
           

摘要

BackgroundHelicobacter pyloriinfection is a major cause of non-cardia gastric cancer (NCGC), but its causal role in cardia gastric cancer (CGC) is unclear. Moreover, the reported magnitude of association with NCGC varies considerably, leading to uncertainty about population-basedH pyloriscreening and eradication strategies in high-risk settings, particularly in China, where approximately half of all global gastric cancer cases occur. Our aim was to assess the associations ofH pyloriinfection, both overall and for individual infection biomarkers, with the risks of NCGC and CGC in Chinese adults.MethodsA case-cohort study was done in adults from the prospective China Kadoorie Biobank study, aged 30–79 years from ten areas in China (Qingdao, Haikou, Harbin, Suzhou, Liuzhou, Henan, Sichuan, Hunan, Gansu, and Zhejiang), and included 500 incident NCGC cases, 437 incident CGC cases, and 500 subcohort participants who were cancer-free and alive within the first two years since enrolment in 2004–08.H pyloribiomarkers were measured in stored baseline plasma samples using a sensitive immunoblot assay (HelicoBlot 2.1), with adapted criteria to defineH pyloriseropositivity. Cox regression was used to estimate adjusted hazard ratios (HRs) for NCGC and CGC associated withH pyloriinfection. These values were used to estimate the number of gastric cancer cases attributable toH pyloriinfection in China.FindingsOf the 512?715 adults enrolled in the China Kadoorie Biobank between June, 2004, and July, 2008, 500 incident NCGC cases, 437 incident CGC cases, and 500 subcohort participants were selected for analysis. The seroprevalence ofH pyloriwas 94·4% (95% CI 92·4–96·4) in NGCG, 92·2% (89·7–94·7) in CGC, and 75·6% (71·8–79·4) in subcohort participants.H pyloriinfection was associated with adjusted HRs of 5·94 (95% CI 3·25–10·86) for NCGC and 3·06 (1·54–6·10) for CGC. Among the seven individual infection biomarkers, cytotoxin-associated antigen had the highest HRs for both NCGC (HR 4·41, 95% CI 2·60–7·50) and CGC (2·94, 1·53–5·68). In this population, 78·5% of NCGC and 62·1% of CGC cases could be attributable toH pyloriinfection.H pyloriinfection accounted for an estimated 339?955 cases of gastric cancer in China in 2018.InterpretationAmong Chinese adults,H pyloriinfection is common and is the cause of large numbers of gastric cancer cases. Population-based mass screening and the eradication ofH pylorishould be considered to reduce the burden of gastric cancer in high-risk settings.FundingCancer Research UK, Wellcome Trust, UK Medical Research Council, British Heart Foundation, Kadoorie Charitable Foundation, National Key Research and Development Program of China, and National Natural Science Foundation of China.
机译:背景光杆菌纤维纤维是非贲门胃癌(NCGC)的主要原因,但它在贲门胃癌(CGC)中的因果作用尚不清楚。此外,报告的与NCGC的关联程度大幅不同,导致人群的幽门屏蔽和高风险环境中的根除策略,特别是在中国,大约一半的全球胃癌病例发生。我们的目的是评估总体和个体感染生物标志物的H幽门螺酰胺纤维的关联,其中NCGC和CGC中的中国成人的风险。在预期中国Kadoorie Biobank研究中的成人中,在30-79岁的成人中进行了案例 - 队列研究从中国十个地区(青岛,海口,哈尔滨,苏州,柳州,河南,四川,湖南,甘肃和浙江省),并包括500个事件NCGC案件,437件CGC案件,500例患有抗癌的参与者在前两年内活着,自2004-08.H幽门螺磁族胶质标志物中的储存基线等离子体样品中使用敏感免疫印迹测定(Helicoblot 2.1)测量,具有调整标准,以限定幽门螺旋偏移性。 Cox回归用于估计NCGC和CGC的调整后危险比(HRS)与H幽门螺杆菌相关联。这些值用于估计中国胃癌病例的数量可归因于中国的胃癌致幽门螺杆菌。512年6月715日,2008年6月至7月,2008年7月,2008年7月,437例,CGC案件,437例,CGC案件,437件入场,选择500个子斗争参与者进行分析。 NGCG,92·2%(89·7-94·4)的H幽门螺杆菌94·4%(95%CI 92·4-96·4),75·6%(71·8-79 ·4)在子座位参与者中,对于NCGC,CGC和3·06(1·54-6·10·10)的调节HRS为5·94(95%CI 3·25-10·86)相关。在七种单独的感染生物标志物中,细胞毒素相关的抗原具有NCGC(HR 4·41,95%CI 2·60-7·50)和CGC(2·94,1·53-5·68)的最高HRS 。在这个人群中,78·5%的NCGC和62·1%的CGC病例可归因于幽门螺杆菌纤维.H幽门螺缩素染色占估计339?2018年中国胃癌955例。interpretationamong中国成人,H幽门螺杆菌是常见的并且是大量胃癌病例的原因。基于人口的大规模筛选和根除幽门螺杆般的胃癌,以减少高风险的环境中胃癌的负担。特惠文化学研究英国,惠康信托,英国医学研究委员会,英国心脏基础,Kadoorie慈善基金会,国家重点研究和发展中国的计划,国家自然科学基金。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号